Puma Biotechnology Inc — Cash Flow (NASDAQ:PBYI) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics

Quarterly Annual

Cash from operating activities 773 K20.65 M-15.83 M27.01 M38.92 M41.8 M 41.8 M Cash from investing activities 23.4 M-10.88 M7.1 M-19.13 M-20.44 M-36.19 M -36.19 M Cash from financing activities 68 K-31.93 M12.22 M0-33.85 M-45.2 M -45.2 M Free cash flow -19.23 M20.65 M-15.83 M14.37 M38.86 M41.73 M 41.73 M

Puma Biotechnology Inc

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

뉴스

Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?

Agios Pharmaceuticals (AGIO) Moves 14.3% Higher: Will This Strength Last?

Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why

IRWD vs. PBYI: Which Small-Cap Biotech Stock Is a Better Buy?

퓨마 바이오, TD Cowen 컨퍼런스 참가: 전략적 성장과 재정 건전성

PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View

Puma Biotechnology, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:PBYI) 2026-02-27

Puma Biotech (PBYI) Q4 Earnings and Revenues Beat Estimates

Puma Biotech Q4 실적, 수익 예상치를 넘어

Jazz Pharmaceuticals (JAZZ) Beats Q4 Earnings and Revenue Estimates

Exelixis (EXEL) Q4 Earnings and Revenues Beat Estimates

Is VTI a Good ETF? A Quick Snapshot for Investors —1/21/25 - TipRanks.com